SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,886.00 50.22
( 0.07%)

Global Indices

Nasdaq

52,223.83 255.58
(0.49%)

Dow Jones

7,434.43 1.45
(0.02%)

Hang Seng

64,889.11 277.96
(0.43%)

Nikkei 225

10,802.25 66.02
(0.61%)

Forex

USD-INR

96.67 0.19
(0.20%)

EUR-INR

110.18 0.12
(0.10%)

GBP-INR

129.04 -0.01
(0.00%)

JPY-INR

0.59 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

66.2307167

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

60.56

3826.28

EPS(TTM)

Face Value()

Div & Yield %

6.3

0.03

Back

aditya birla capital ltd

Coromandel International consolidated net profit declines 24.59% in the June 2026 quarter

Jul 23,2026

Net profit of Coromandel International declined 24.59% to Rs 380.82 crore in the quarter ended June 2026 as against Rs 505.01 crore during the previous quarter ended June 2025. Sales rose 15.94% to Rs 8164.77 crore in the quarter ended June 2026 as against Rs 7042.30 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	8164.77	7042.30	16
OPM %	9.26	11.11	-
PBDT	716.44	797.86	-10
PBT	513.68	677.28	-24
NP	380.82	505.01	-25

76,886.00 50.22 ( 0.07%)

52,223.83 255.58 (0.49%)

7,434.43 1.45 (0.02%)

64,889.11 277.96 (0.43%)

10,802.25 66.02 (0.61%)

96.67 0.19 (0.20%)

110.18 0.12 (0.10%)

129.04 -0.01 (0.00%)

0.59 0.00 (-0.04%)